Literature DB >> 12070044

Enhancement of G-CSF-induced stem cell mobilization by antibodies against the beta 2 integrins LFA-1 and Mac-1.

Gerjo A Velders1, Johannes F M Pruijt, Perry Verzaal, Ronald van Os, Yvette van Kooyk, Carl G Figdor, Evert-Jan F M de Kruijf, Roel Willemze, Willem E Fibbe.   

Abstract

The beta 2 integrins leukocyte function antigen-1 (LFA-1, CD11a) and macrophage antigen-1 (Mac-1, CD11b) have been reported to play a role in the attachment of CD34(+) cells to stromal cells in the bone marrow. When administered prior to interleukin-8 (IL-8), anti-LFA-1 antibodies completely prevent the IL-8-induced mobilization of hematopoietic stem cells in mice. Here, we studied the role of anti-beta 2 integrin antibodies in granulocyte colony-stimulating factor (G-CSF)-induced mobilization of hematopoietic progenitor cells. Administration of antibodies against the alpha chain of LFA-1 or against the alpha chain of Mac-1 followed by daily injections of G-CSF for more than 1 day resulted in a significant enhancement of mobilization of hematopoietic progenitor cells when compared with mobilization induced by G-CSF alone. Also, the number of late (day 28) cobblestone area-forming cells in vitro was significantly higher after mobilization with anti-LFA-1 antibodies followed by 5 microg G-CSF for 5 days than with G-CSF alone (119 +/- 34 days vs 17 +/- 14 days), indicating mobilization of repopulating stem cells. Pretreatment with blocking antibodies to intercellular adhesion molecule-1 (ICAM-1; CD54), a ligand of LFA-1 and Mac-1, did not result in an effect on G-CSF-induced mobilization, suggesting that the enhancing effect required an interaction of the beta 2 integrins and one of their other ligands. Enhancement of mobilization was not observed in LFA-1-deficient (CD11a) mice, indicating that activated cells expressing LFA-1 mediate the synergistic effect, rather than LFA-1-mediated adhesion.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12070044     DOI: 10.1182/blood.v100.1.327

Source DB:  PubMed          Journal:  Blood        ISSN: 0006-4971            Impact factor:   22.113


  11 in total

1.  c-Myc controls the balance between hematopoietic stem cell self-renewal and differentiation.

Authors:  Anne Wilson; Mark J Murphy; Thordur Oskarsson; Konstantinos Kaloulis; Michael D Bettess; Gabriela M Oser; Anne-Catherine Pasche; Christian Knabenhans; H Robson Macdonald; Andreas Trumpp
Journal:  Genes Dev       Date:  2004-11-15       Impact factor: 11.361

Review 2.  Harnessing bone marrow resident regulatory T cells to improve allogeneic stem cell transplant outcomes.

Authors:  Laetitia Le Texier; Katie E Lineburg; Kelli P A MacDonald
Journal:  Int J Hematol       Date:  2016-12-10       Impact factor: 2.490

3.  Beta-glucan enhances complement-mediated hematopoietic recovery after bone marrow injury.

Authors:  Daniel E Cramer; Daniel J Allendorf; Jarek T Baran; Richard Hansen; Jose Marroquin; Bing Li; Janina Ratajczak; Mariusz Z Ratajczak; Jun Yan
Journal:  Blood       Date:  2005-09-22       Impact factor: 22.113

Review 4.  Hematopoietic stem and progenitor cell trafficking.

Authors:  Irina B Mazo; Steffen Massberg; Ulrich H von Andrian
Journal:  Trends Immunol       Date:  2011-07-29       Impact factor: 16.687

5.  Targeting VLA4 integrin and CXCR2 mobilizes serially repopulating hematopoietic stem cells.

Authors:  Darja Karpova; Michael P Rettig; Julie Ritchey; Daniel Cancilla; Stephanie Christ; Leah Gehrs; Ezhilarasi Chendamarai; Moses O Evbuomwan; Matthew Holt; Jingzhu Zhang; Grazia Abou-Ezzi; Hamza Celik; Eliza Wiercinska; Wei Yang; Feng Gao; Linda G Eissenberg; Richard F Heier; Stacy D Arnett; Marvin J Meyers; Michael J Prinsen; David W Griggs; Andreas Trumpp; Peter G Ruminski; Dwight M Morrow; Halvard B Bonig; Daniel C Link; John F DiPersio
Journal:  J Clin Invest       Date:  2019-05-14       Impact factor: 14.808

6.  CD11a is essential for normal development of hematopoietic intermediates.

Authors:  Tina O Bose; Sara L Colpitts; Quynh-Mai Pham; Lynn Puddington; Leo Lefrançois
Journal:  J Immunol       Date:  2014-08-08       Impact factor: 5.422

7.  Comparison of the efficacy of hematopoietic stem cell mobilization regimens: a systematic review and network meta-analysis of preclinical studies.

Authors:  Chengxin Luo; Li Wang; Guixian Wu; Xiangtao Huang; Yali Zhang; Yanni Ma; Mingling Xie; Yanni Sun; Yarui Huang; Zhen Huang; Qiuyue Song; Hui Li; Yu Hou; Xi Li; Shuangnian Xu; Jieping Chen
Journal:  Stem Cell Res Ther       Date:  2021-05-29       Impact factor: 6.832

8.  Expression of adhesion molecules on CD34+ cells from steady-state bone marrow before and after mobilization and their association with the yield of CD34+ cells.

Authors:  Karin Zattar Cecyn; Eliza Y S Kimura; Dulce Marta S M Lima; Miyoko Yamamoto; José Orlando Bordin; José Salvador R de Oliveira
Journal:  Blood Res       Date:  2018-03-27

9.  Therapeutic targeting and rapid mobilization of endosteal HSC using a small molecule integrin antagonist.

Authors:  Benjamin Cao; Zhen Zhang; Jochen Grassinger; Brenda Williams; Chad K Heazlewood; Quentin I Churches; Simon A James; Songhui Li; Thalia Papayannopoulou; Susan K Nilsson
Journal:  Nat Commun       Date:  2016-03-15       Impact factor: 14.919

10.  Five Days Granulocyte Colony-Stimulating Factor Treatment Increases Bone Formation and Reduces Gap Size of a Rat Segmental Bone Defect: A Pilot Study.

Authors:  Marietta Herrmann; Stephan Zeiter; Ursula Eberli; Maria Hildebrand; Karin Camenisch; Ursula Menzel; Mauro Alini; Sophie Verrier; Vincent A Stadelmann
Journal:  Front Bioeng Biotechnol       Date:  2018-02-12
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.